Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784063 · ClinicalTrials.gov registry record · NA
Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06784063 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 40 participants.
The verdict
NCT06784063, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.
Interventions
- DEVICE Clareon Vivity Extended Vision IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-04-10 |
| Est. Completion | 2025-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06784063
The ClinicalTrials.gov registry entry for NCT06784063 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clareon Vivity Extended Vision IOL is the first listed.
NCT06784063 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06784063 about?
NCT06784063 is a clinical study titled "Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)". The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.
What is the current status of trial NCT06784063?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-10. Estimated completion is 2025-06-13.
What interventions are being tested in trial NCT06784063?
The interventions under investigation include: Clareon Vivity Extended Vision IOL (DEVICE).
Who is sponsoring clinical trial NCT06784063?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.